Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$2.76 - $4.72 $28,345 - $48,474
10,270 New
10,270 $44,000
Q4 2022

Feb 07, 2023

BUY
$3.05 - $5.49 $31,323 - $56,382
10,270 New
10,270 $32,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.